Published in Mutat Res on August 09, 2007
Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis (2008) 1.03
Comet assay to measure DNA repair: approach and applications. Front Genet (2014) 0.95
Genetic variability in DNA repair proteins in age-related macular degeneration. Int J Mol Sci (2012) 0.83
Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev (2012) 0.81
Bulky DNA adducts in white blood cells: a pooled analysis of 3,600 subjects. Cancer Epidemiol Biomarkers Prev (2010) 0.80
Do GST polymorphisms modulate the frequency of chromosomal aberrations in healthy subjects? Environ Health Perspect (2009) 0.75
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis (2012) 1.28
Formation of indigo by recombinant mammalian cytochrome P450. Biochem Biophys Res Commun (1999) 1.24
DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res (2007) 1.22
Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Drug Metab Dispos (1998) 1.15
Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer (2004) 1.11
Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet (2001) 1.08
Replication of restless legs syndrome loci in three European populations. J Med Genet (2009) 1.08
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis (2014) 1.04
Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. Mutagenesis (2012) 1.00
Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and urinary 1-hydroxypyrene in foundry workers. Cancer Epidemiol Biomarkers Prev (1993) 0.98
Localization of male-specifically expressed MROS genes of Silene latifolia by PCR on flow-sorted sex chromosomes and autosomes. Genetics (2001) 0.91
Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer? Mutat Res (2008) 0.90
Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum Mutat (2009) 0.89
Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe. Neoplasma (2010) 0.88
Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol (1997) 0.88
Accumulation of the proteolytic marker peptide ubiquitin in the trophoblast of mammalian blastocysts. Cloning Stem Cells (2001) 0.87
Biomonitoring of genotoxic risk in workers in a rubber factory: comparison of the Comet assay with cytogenetic methods and immunology. Mutat Res (1999) 0.87
Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat Res (2001) 0.87
An evaluation of styrene genotoxicity using several biomarkers in a 3-year follow-up study of hand-lamination workers. Mutat Res (1999) 0.86
Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics (2000) 0.86
Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. Carcinogenesis (2010) 0.85
Depurination from DNA of 7-methylguanine, 7-(2-aminoethyl)-guanine and ring-opened 7-methylguanines. Chem Biol Interact (1989) 0.85
Human DNA adducts of 1,3-butadiene, an important environmental carcinogen. Carcinogenesis (2000) 0.85
Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3. Eur J Biochem (2000) 0.85
Adenine N3 is a main alkylation site of styrene oxide in double-stranded DNA. Chem Biol Interact (2000) 0.84
Biomonitoring of occupational exposure to styrene in a plastics lamination plant. Mutat Res (1999) 0.84
Cytotoxicity of cyclophosphamide, paclitaxel, and docetaxel for tumor cell lines in vitro: effects of concentration, time and cytochrome P450-catalyzed metabolism. Arch Toxicol (2000) 0.83
Uptake, distribution, and formation of hemoglobin and DNA adducts after inhalation of C2-C8 1-alkenes (olefins) in the rat. Carcinogenesis (1995) 0.83
Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond) (2009) 0.83
Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression. Arch Toxicol (1999) 0.82
Screening for conditions of public health importance in people arriving in Australia by boat without authority. Med J Aust (2002) 0.82
Metabolism of new-generation taxanes in human, pig, minipig and rat liver microsomes. Xenobiotica (2006) 0.82
The role of various biomarkers in the evaluation of styrene genotoxicity. Cancer Detect Prev (2003) 0.81
Relationship between genotoxicity biomarkers in somatic and germ cells: findings from a biomonitoring study. Mutagenesis (2006) 0.81
Ornithine decarboxylase G316A genotype and colorectal cancer risk. Colorectal Dis (2010) 0.80
Quantitative aspects of 32P-postlabeling. Prog Clin Biol Res (1991) 0.80
Optimization of an HPLC method for analyses of 32P-postlabeled DNA adducts. Carcinogenesis (1993) 0.80
[Breast cancer: an overview of factors affecting the onset and development of the disease]. Cas Lek Cesk (2002) 0.80
DNA adducts of 1,3-butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ Mol Mutagen (2001) 0.80
The role of CYP2E1 and 2B1 in metabolic activation of benzene derivatives. Arch Toxicol (1996) 0.80
Styrene: from characterisation of DNA adducts to application in styrene-exposed lamination workers. Toxicol Lett (1995) 0.79
Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Res Vet Sci (2004) 0.79
32P-postlabeling of DNA adducts of styrene-exposed lamination workers. Carcinogenesis (1993) 0.79
Development of in vivo derived diploid and tetraploid pig embryos in a modified medium NCSU 37. Theriogenology (2004) 0.79
Styrene oxide-induced HPRT mutations, DNA adducts and DNA strand breaks in cultured human lymphocytes. Carcinogenesis (1995) 0.79
Long-term results of pars plana vitrectomy and silicone oil for giant tears. Eur J Ophthalmol (1997) 0.79
Determination of malonaldehyde-modified 2'-deoxyguanosine-3'-monophosphate and DNA by 32P-postlabelling. Carcinogenesis (1992) 0.78
CYP1B1 gene polymorphism modifies pancreatic cancer risk but not survival. Neoplasma (2010) 0.78
Synthesis and stability of 2'-deoxyguanosine 3'-monophosphate adducts of dimethyl sulfate, ethylene oxide and styrene oxide. Chem Biol Interact (1990) 0.78
Gentiana asclepiadea and Armoracia rusticana can modulate the adaptive response induced by zeocin in human lymphocytes. Neoplasma (2012) 0.78
[Genetic polymorphism of biotransforming enzymes and genotoxic effects of styrenes]. G Ital Med Lav Ergon (2004) 0.78
DNA repair and cyclin D1 polymorphisms and styrene-induced genotoxicity and immunotoxicity. Toxicol Appl Pharmacol (2005) 0.78
Transcriptomic analysis of in vivo and in vitro produced bovine embryos revealed a developmental change in cullin 1 expression during maternal-to-embryonic transition. Theriogenology (2011) 0.78
Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST. Nanotoxicology (2015) 0.77
The use of biomarkers for risk assessment: Reporting from the INTARESE/ENVIRISK Workshop in Prague. Int J Hyg Environ Health (2010) 0.77
Short term oxidative DNA damage by hyperbaric oxygenation in patients with chronic leg ulcers. Bratisl Lek Listy (2011) 0.77
Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes. Chem Biol Interact (1998) 0.77
Cytochromes P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ Health Perspect (1996) 0.77
Future research directions in the use of biomarkers. Environ Health Perspect (1996) 0.77
The association between glutathione S-transferase gene polymorphisms and pancreatic cancer in a central European Slavonic population. Mutat Res (2009) 0.77
Exposure to various benzene derivatives differently induces cytochromes P450 2B1 and P450 2E1 in rat liver. Arch Toxicol (1993) 0.77
Identification of 1-adenine DNA adducts in workers occupationally exposed to styrene. J Occup Environ Med (2001) 0.77
Different effects of newly isolated saponins on the mutagenicity and cytotoxicity of the anticancer drugs mitomycin C and bleomycin in human lymphocytes. Mutat Res (1998) 0.77
Evaluation of cytogenetic and DNA damage in mitochondrial disease patients: effects of coenzyme Q10 therapy. Mutagenesis (2004) 0.76
Retinoid X receptor suppresses transformation by the v-myb oncogene. J Leukoc Biol (1999) 0.76
Lipid peroxidation in men after dietary supplementation with a mixture of antioxidant nutrients. Bratisl Lek Listy (2004) 0.76
Titanium dioxide nanoparticles: some aspects of toxicity/focus on the development. Endocr Regul (2015) 0.76
Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama). Chem Biol Interact (2001) 0.76
Vitamin C protective plasma value. Bratisl Lek Listy (2007) 0.76
Aneuploidy and diploidy rates in sperm of five men after three-colour hybridization: indication of X chromosome-associated autosome 2 aneuploidy. Mutat Res (1998) 0.75
Culture of bovine oocytes from small antral follicles in meiosis-inhibiting medium with butyrolactone I: RNA synthesis, nucleolar morphology and meiotic competence. Anim Reprod Sci (2000) 0.75
[ Findings on optical coherence tomography in patients with macular degeneration treated with photodynamic therapy using Visudyne]. Cesk Slov Oftalmol (2003) 0.75